top of page
Mukherjee Lab Lung Autoimmunity

PUBLICATIONS

Coming soon...

Up‐dosing of reslizumab in severe asthmatics with persistent sputum eosinophilia: A feasibility study

Sept 17, 2024

Response of sputum periostin to anti‐T2 biologics treatment in severe asthma

Apr 23, 2024

Phosphoinositide-3 kinase activity in severe eosinophilic asthma with recurrent airway infections and neutrophilic exacerbations

Mar 11, 2024

Eosinophil-mucus interplay in severe asthma: Implications for treatment with biologicals

July, 2024

Sputum cytokines associated with raised FeNO after anti‐IL5 biologic therapy in severe asthma

Jan 10, 2024

Benralizumab attenuates blood and airway eosinophilia in severe asthmatics with inadequate response to anti-IL-5 neutralizing antibodies

Oct 12, 2023

Autoantibody-mediated macrophage dysfunction in severe asthmatics with airway infections

Oct 26, 2022

Circulating autoantibodies in post-acute sequalae of COVID-19

Sept 22, 2022

A polyclonal airway autoimmune response is associated with clinical indices of asthma severity 

July 1, 2022

A unique Cd27-IgD B-cells population in the sputum of severe eosinophilic asthma associated with airway autoimmunity

October 2022

Sub-optimal treatment response to anti IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena

October 8, 2020

Sputum ANCA in serum ANCA-negative  eosinophilic  granulomatosis with polyangiitis (eGPA)

January 15, 2019

Sputum autoantibodies in severe eosinophilic asthma

July 24, 2018

Clinical case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy 

January 6, 2017

bottom of page